QLGN   $0.17  6.25% Market Closed After Close 0.1601 -5.82%

Qualigen Therapeutics Inc
Total Cash 118.69K
totalCashPerShare 0.01
EBITDA -8.33M
Total Debt 1.67M
quickRatio 0.025
currentRatio 0.111
Total Revenue
debtToEquity
Revenue/Share
ROA -0.75073
ROE
grossProfits
freeCashflow -4.66M
operatingCashflow -7.00M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 3.53M
forwardPE
floatShares 12.15M
sharesOutstanding 27.02M
sharesShort 108.95K
sharesShortPriorMonth 613.36K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.01%
Short Ratio help_outline 0.36%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -0.445
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -9.27M
trailingEps -1.64%
forwardEps -1.00%
enterpriseToEbitda -0.42
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2023
institutionsCount 22
lastUpdated Oct. 16, 2024, 9:47 p.m.